Strongbridge Biopharma plc
SBBP · NASDAQ
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45,075 | -$49,451 | $31,851 | -$113,483 |
| Dep. & Amort. | $5,107 | $5,099 | $7,233 | $5,032 |
| Deferred Tax | $0 | $0 | $0 | $1,958 |
| Stock-Based Comp. | $7,381 | $8,597 | $7,807 | $5,167 |
| Change in WC | $11,971 | -$55,799 | $66,715 | -$3,310 |
| Other Non-Cash | -$17,518 | $46,770 | -$198,182 | $59,300 |
| Operating Cash Flow | -$38,134 | -$44,784 | -$84,576 | -$45,336 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10 | -$74 | -$326 | $0 |
| Net Acquisitions | $0 | $0 | $135,000 | $0 |
| Inv. Purchases | $0 | -$56,187 | $0 | $0 |
| Inv. Sales/Matur. | $21,122 | $35,500 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$344 | -$7,500 |
| Investing Cash Flow | $21,112 | -$20,761 | $134,330 | -$7,500 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $28,601 | $0 | $64,487 | $26,457 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $47,512 | $87 | $15,226 | $43,509 |
| Financing Cash Flow | $47,512 | $87 | $15,226 | $43,509 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $30,490 | -$65,458 | $64,980 | -$9,327 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57,032 | $122,490 | $57,510 | $66,837 |
| End Cash | $87,522 | $57,032 | $122,490 | $57,510 |
| Free Cash Flow | -$38,144 | -$44,858 | -$84,902 | -$45,336 |